Archives of Virology

, Volume 158, Issue 7, pp 1555–1560

HCV infection among cocaine users in the state of Pará, Brazilian Amazon

  • Aldemir B. Oliveira-Filho
  • Leila Sawada
  • Laine C. Pinto
  • Daiane Locks
  • Santana L. Bahia
  • I. Brasil-Costa
  • José Alexandre R. Lemos
Brief Report

Abstract

In this study, the prevalence, genotype frequency, and risk factors for HCV infection in 384 cocaine users were determined. One hundred twenty-four (32.3 %) cocaine users had anti-HCV antibodies and 120 (31.3 %) had HCV-RNA. Genotyping results indicated the predominance of genotypes 1 (73.3 %) and 3 (26.7 %). Multivariate analysis showed an association of HCV infection with tattoos, shared use of paraphernalia, daily cocaine use, and a long history of cocaine use. The epidemiological aspects of HCV infection among cocaine users presented here should serve as an incentive for the establishment of a program of hepatitis C prevention and control by the local public-health authorities in the Amazon.

References

  1. 1.
    Aaron S, McMahon JM, Milano D et al (2008) Intranasal transmission of hepatitis C virus: virological and clinical evidence. Clin Infect Dis 47:931–934PubMedCrossRefGoogle Scholar
  2. 2.
    Aceijas C, Rhodes T (2007) Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 18:352–358PubMedCrossRefGoogle Scholar
  3. 3.
    Allison RD, Conry-Cantilena C, Koziol D et al (2012) A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donors. J Infect Dis 206:654–661PubMedCrossRefGoogle Scholar
  4. 4.
    Alter MJ (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol 13:2436–2441PubMedGoogle Scholar
  5. 5.
    Amon JJ, Garfein RS, Ahdieh-Grant L et al (2008) Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the United States, 1994–2004. Clin Infect Dis 46:1852–1858PubMedCrossRefGoogle Scholar
  6. 6.
    Caiaffa WT, Zocratto KF, Osimani ML et al (2010) Hepatitis C virus among non-injecting cocaine users (NICUs) in South America: can injectors be a bridge? Addiction 106:143–151PubMedCrossRefGoogle Scholar
  7. 7.
    Campiotto S, Pinho JR, Carrilho FJ et al (2005) Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 38:41–49PubMedCrossRefGoogle Scholar
  8. 8.
    Campollo O, Roman S, Panduro A et al (2012) Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico. Drug Alcohol Depend 123:269–272PubMedCrossRefGoogle Scholar
  9. 9.
    Carvalho HB, Seibel SD, Burattini MN, Massad E, Reingold A (2003) Hepatitis B and C and syphilis vulnerability related infections among institutionalized disadvantaged youth in São Paulo-Brazil. J Bras Doenças Sex Transm 15:41–45Google Scholar
  10. 10.
    Fischer B, Powis J, Firestone Cruz M (2008) Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia. Eur J Gastroenterol Hepatol 20:29–32PubMedCrossRefGoogle Scholar
  11. 11.
    Galperim B, Cheinquer H, Stein A et al (2004) Intranasal cocaine use does not appear to be an independent risk factor for HCV infection. Addiction 99:973–977PubMedCrossRefGoogle Scholar
  12. 12.
    Gelberg L, Robertson MJ, Arangua L et al (2012) Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles. Public Health Rep 127:407–421PubMedGoogle Scholar
  13. 13.
    Hermanstyne KA, Bangsberg DR, Hennessey K et al (2012) The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco. J Public Health (Oxf) 34:330–339CrossRefGoogle Scholar
  14. 14.
    Jafari S, Copes R, Baharlou S et al (2010) Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis. doi:10.1016/j.ijid.2010.03.019 Google Scholar
  15. 15.
    Lopes CL, Teles SA, Espírito-Santo MP et al (2009) Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil. Rev Saude Publica 43:43–50PubMedCrossRefGoogle Scholar
  16. 16.
    Macías J, Palacios RB, Claro E et al (2008) High prevalence of hepatitis C virus infection among non-injecting drug users: association with sharing the inhalation implements of crack. Liver Int 28:781–786PubMedCrossRefGoogle Scholar
  17. 17.
    Martinez A, Talal AH (2008) Non-injection drug use: an under-appreciated risk factor for hepatitis C virus transmission. Liver Int 28:757–760PubMedCrossRefGoogle Scholar
  18. 18.
    Martins T, Narciso-Schiavon JL, Schiavon LL (2011) Epidemiology of hepatitis C virus infection. Rev Assoc Med Bras 57:107–112PubMedCrossRefGoogle Scholar
  19. 19.
    McMahon JM, Tortu S (2003) A potential hidden source of hepatitis C infection among non-injecting drug users. J Psychoactive Drugs 35:455–460PubMedCrossRefGoogle Scholar
  20. 20.
    McMahon JM, Simm M, Milano D, Clatts M (2004) Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user. Ann Clin Microbiol Antimicrob. doi:10.1186/1476-0711-3-6 PubMedGoogle Scholar
  21. 21.
    Morice Y, Cantaloube JF, Beaucourt S et al (2006) Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol 78:1296–1303PubMedCrossRefGoogle Scholar
  22. 22.
    Murakami J, Nagata I, Iitsuka T et al (2012) Risk factors for mother-to-child transmission of hepatitis C virus: Maternal high viral load and fetal exposure in the birth canal. Hepatol Res 42:648–657PubMedCrossRefGoogle Scholar
  23. 23.
    Novais AC, Lopes CL, Reis NR et al (2009) Prevalence of hepatitis C virus infection and associated factors among male illicit drug users in Cuiabá, Mato Grosso, Brazil. Mem Inst Oswaldo Cruz 104:892–896PubMedCrossRefGoogle Scholar
  24. 24.
    Oliveira-Filho AB, Pimenta AS, Rojas MF et al (2010) Likely transmission of hepatitis C virus through sharing of cutting and perforating instruments in blood donors in the State of Pará, Northern Brazil. Cad Saude Publica 26:837–844PubMedCrossRefGoogle Scholar
  25. 25.
    Oliveira-Filho AB, Pimenta AS, Rojas MF et al (2010) Prevalence and genotyping of hepatitis C virus in blood donors in the state of Pará, Northern Brazil. Mem Inst Oswaldo Cruz 105:103–106PubMedCrossRefGoogle Scholar
  26. 26.
    Oliveira-Filho AB, Oliveira EH, Castro JAA, Silva LV, Vallinoto ACR, Lemos JAR (2012) Epidemiological aspects of HCV infection in HIV-infected individuals in Piauí State Northeast Brazil. Arch Virol. doi:10.1007/s00705-012-1435-3 PubMedGoogle Scholar
  27. 27.
    Prati D (2006) Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol 45:607–616PubMedCrossRefGoogle Scholar
  28. 28.
    Sawada L, Pinheiro AC, Locks D et al (2011) Distribution of hepatitis C virus genotypes among different exposure categories in the State of Pará, Brazilian Amazon. Rev Soc Bras Med Trop 44:8–12PubMedCrossRefGoogle Scholar
  29. 29.
    Scheinmann R, Hagan H, Lelutiu-Weinberger C et al (2007) Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend 89:1–12PubMedCrossRefGoogle Scholar
  30. 30.
    Segurado AC, Braga P, Etzel A, Cardoso MR (2004) Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors. AIDS Patient Care STDS 18:135–143PubMedCrossRefGoogle Scholar
  31. 31.
    Silva MB, Andrade TM, Silva LK et al (2010) Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil. Mem Inst Oswaldo Cruz 105:299–303PubMedCrossRefGoogle Scholar
  32. 32.
    Terrault NA, Dodge JL, Murphy EL et al (2012) Sexual transmission of HCV among monogamous heterosexual couples: the HCV partners study. Hepatology. doi:10.1002/hep.26164 PubMedGoogle Scholar
  33. 33.
    van den Berg CH, van de Laar TJ, Kok A et al (2009) Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies. J Viral Hepat 16:568–577PubMedCrossRefGoogle Scholar
  34. 34.
    Wang CC, Krantz E, Klarquist J et al (2007) Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis 196:1474–1482PubMedCrossRefGoogle Scholar
  35. 35.
    Xia X, Luo J, Bai J, Yu R (2008) Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health 122:990–1003PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  • Aldemir B. Oliveira-Filho
    • 1
    • 2
  • Leila Sawada
    • 2
    • 3
  • Laine C. Pinto
    • 2
    • 3
  • Daiane Locks
    • 2
    • 3
  • Santana L. Bahia
    • 2
    • 3
  • I. Brasil-Costa
    • 2
    • 3
  • José Alexandre R. Lemos
    • 2
    • 3
  1. 1.Faculdade de Ciências NaturaisCampus do Marajó, Breves, Universidade Federal do ParáBrevesBrazil
  2. 2.Laboratório de Biologia MolecularCentro de Hematologia e Hemoterapia do ParáBelémBrazil
  3. 3.Instituto de Ciências Biológicas, Universidade Federal do ParáBelémBrazil

Personalised recommendations